JP2024516969A5 - - Google Patents

Info

Publication number
JP2024516969A5
JP2024516969A5 JP2023564664A JP2023564664A JP2024516969A5 JP 2024516969 A5 JP2024516969 A5 JP 2024516969A5 JP 2023564664 A JP2023564664 A JP 2023564664A JP 2023564664 A JP2023564664 A JP 2023564664A JP 2024516969 A5 JP2024516969 A5 JP 2024516969A5
Authority
JP
Japan
Application number
JP2023564664A
Other languages
Japanese (ja)
Other versions
JPWO2022235557A5 (https=
JP2024516969A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/027261 external-priority patent/WO2022235557A1/en
Publication of JP2024516969A publication Critical patent/JP2024516969A/ja
Publication of JP2024516969A5 publication Critical patent/JP2024516969A5/ja
Publication of JPWO2022235557A5 publication Critical patent/JPWO2022235557A5/ja
Pending legal-status Critical Current

Links

JP2023564664A 2021-05-04 2022-05-02 代謝性疾患の治療のためのラクトイルアミノ酸 Pending JP2024516969A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163183868P 2021-05-04 2021-05-04
US63/183,868 2021-05-04
PCT/US2022/027261 WO2022235557A1 (en) 2021-05-04 2022-05-02 Lactoyl amino acids for the treatment of metabolic disease

Publications (3)

Publication Number Publication Date
JP2024516969A JP2024516969A (ja) 2024-04-18
JP2024516969A5 true JP2024516969A5 (https=) 2025-04-24
JPWO2022235557A5 JPWO2022235557A5 (https=) 2025-04-24

Family

ID=83932803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564664A Pending JP2024516969A (ja) 2021-05-04 2022-05-02 代謝性疾患の治療のためのラクトイルアミノ酸

Country Status (7)

Country Link
US (1) US20240189266A1 (https=)
EP (1) EP4313297A4 (https=)
JP (1) JP2024516969A (https=)
KR (1) KR20240006050A (https=)
CN (1) CN117769414A (https=)
AU (1) AU2022271191A1 (https=)
WO (1) WO2022235557A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240122888A1 (en) * 2022-10-03 2024-04-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of phenylalanine and lactate
CN116035217B (zh) * 2022-12-23 2023-08-04 暨南大学 一种具有减肥减脂作用的组合物与应用
WO2024192165A1 (en) * 2023-03-14 2024-09-19 The Board Of Trustees Of The Leland Stanford Junior University N-beta-hydroxybutyryl-amino acids and related compositions and methods
WO2025072489A2 (en) * 2023-09-27 2025-04-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Analogues of n-lactoyl-phenylalanine, methods of synthesis, and methods of use
WO2025184353A1 (en) * 2024-03-01 2025-09-04 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating metabolic disorders
CN118795011B (zh) * 2024-06-28 2025-01-21 合肥工业大学 一种用于细胞代谢产物n-l-乳酰-l-苯丙氨酸的快速检测方法
CN119350175B (zh) * 2024-10-15 2026-03-17 广东药科大学 一类新型酰基苯丙氨酸衍生物、其制备方法及其作为药物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1159146A (zh) * 1995-07-26 1997-09-10 弗门尼舍有限公司 风味产品及其制备方法
AU719332B2 (en) * 1995-09-19 2000-05-04 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
WO2012054528A2 (en) * 2010-10-19 2012-04-26 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies

Similar Documents

Publication Publication Date Title
JP2024516969A5 (https=)
BR102022025291A2 (https=)
CL2025002730A1 (es) Estructuras de reacción microfluídica
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BY13169U (https=)
BY13175U (https=)
CN307045597S (https=)
CN307045554S (https=)
CN307049270S (https=)
CN307045411S (https=)
CN307045332S (https=)
CN307045324S (https=)
CN307047624S (https=)
CN307044403S (https=)
CN307047784S (https=)
BY23966C1 (https=)
BY23965C1 (https=)
BY13165U (https=)
BY13176U (https=)
BY13166U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13141U (https=)